Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment

This study has been completed.
Information provided by (Responsible Party):
Jules Sumkin, University of Pittsburgh Identifier:
First received: April 16, 2010
Last updated: February 24, 2016
Last verified: February 2016
Results First Received: January 25, 2016  
Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Diagnostic
Condition: Breast Abnormalities
Intervention: Device: tomosynthesis and screening mammography

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
Subjects were consented, screened and enrolled at one site, a medical hospital specializing in women's health. The period of recruitment was from May, 2010 to September, 2014.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
Three subjects were deemed ineligible. Two subjects were withdrawn by the PI after beginning research procedures.

Reporting Groups
Digital Breast Tomosynthesis (DBT) Consented and eligible women undergoing baseline screening mammography received DBT

Participant Flow:   Overall Study
    Digital Breast Tomosynthesis (DBT)  
STARTED     1085  
COMPLETED     1080  
Physician Decision                 2  
deemed ineligible after screening                 3  

  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
Participants who completed research procedures

Reporting Groups
Digital Breast Tomosynthesis (DBT) Consented and eligible women undergoing baseline screening mammography received DBT

Baseline Measures
    Digital Breast Tomosynthesis (DBT)  
Number of Participants  
[units: participants]
[units: years]
Mean (Standard Deviation)
  42.03  (3.75)  
[units: participants]
Female     1080  
Male     0  
Ethnicity (NIH/OMB)  
[units: participants]
Hispanic or Latino     10  
Not Hispanic or Latino     1054  
Unknown or Not Reported     16  
Race (NIH/OMB)  
[units: participants]
American Indian or Alaska Native     0  
Asian     35  
Native Hawaiian or Other Pacific Islander     0  
Black or African American     278  
White     751  
More than one race     0  
Unknown or Not Reported     16  
Region of Enrollment  
[units: participants]
United States     1080  

  Outcome Measures

1.  Primary:   Number of Participants Without Cancer Who Were Recalled   [ Time Frame: upon recruitment/enrollment phase completion ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact:  
Name/Title: Dr. Jules H. Sumkin
Organization: University of Pittsburgh
phone: 412-641-1976

Responsible Party: Jules Sumkin, University of Pittsburgh Identifier: NCT01106911     History of Changes
Other Study ID Numbers: PRO09060334
Study First Received: April 16, 2010
Results First Received: January 25, 2016
Last Updated: February 24, 2016
Health Authority: United States: Institutional Review Board